Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Decode the Crosstalk Between Bones, Brain, and Fat

Kathy Holliman  |  Issue: April 2010  |  April 1, 2010

However, bone remodeling also requires energy expenditures for both the osteoclasts and the osteoblasts. Thus, an early hypothesis was that bone mass, appetite, and reproduction may be controlled by the same hormones. Only leptin has been identified as the hormone involved in all three. “Leptin is an adipocyte-derived hormone identified for its ability to regulate energy metabolism and reproduction. It appears during evolution much later than energy metabolism and signals in the brain to fulfill its functions,” he said.

Leptin deficiency has many facets, he said, including behavioral abnormalities, small size of the brain, wound-healing defects, immunity defects, and low sympathetic tone. Reflex sympathetic dystrophy is a disease characterized by localized high sympathetic activity and bone loss. This condition has been successfully treated with beta-blockers.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Function of Leptin

Researchers had several central questions about the function of leptin. “Where does leptin signal in the brain to regulate bone mass accrual? Where does leptin signal in the brain to regulate energy metabolism? Is there a common molecular basis between these two functions of leptin?” Dr. Karsenty listed.

Through research with several mouse models, Dr. Karsenty and colleagues have found that serotonin is the molecular basis of the central coregulation of bone mass and energy metabolism. It is leptin that regulates these two functions by acting in the brainstem and by inhibiting synthesis and release of serotonin. “Leptin inhibits bone mass accrual, and this function occurs independently of its ability to regulate energy metabolism. This function also occurs only through a central relay,” Dr. Karsenty said.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

As explained in the research published in Cell, serotonin is produced in cells of the duodenum and in serotonergic neurons of brainstem and does not cross the blood–brain barrier. Because of this mode of production, serotonin is a molecule “with two distinct functional identities depending on its site of synthesis: a hormone when made in the gut and a neurotransmitter when made in the brain.”1

Those roles had been previously known, but serotonin’s role in bone mass had not been identified. Dr. Karsenty and colleagues showed that brain-derived serotonin favors bone mass accrual and appetite, unlike leptin. It is leptin that regulates those functions by inhibiting serotonin synthesis in the neurons of the brainstem.

Mouse Models Instrumental

A series of mouse models were critical to this research, Dr. Karsenty said. For example, one mouse model was unable to synthesize serotonin anywhere in its body. By using this mouse model, the researchers hoped to ascertain the contribution of the brain-derived serotonin on regulation of bone mass accrual. These mice had a low bone mass, a decrease in bone formation, and an increase in bone resorption, thus indicating the role that the brain-derived serotonin has in regulation of bone mass.

Page: 1 2 3 | Single Page
Share: 

Filed under:ConditionsOsteoarthritis and Bone DisordersResearch Rheum Tagged with:bone remodelingGenesOsteoporosisResearch

Related Articles

    What Fat Does to Arthritis

    August 1, 2011

    The role of adipokines in the pathogenesis of rheumatic diseases

    How Energy Shifts Lead to Systemic Illness

    July 12, 2011

    The impact of adaptive energy programs on the manifestations of chronic inflammatory disease

    New Treatments Needed to Prevent Fractures in Osteoporosis

    June 1, 2014

    Current therapies target pathways of bone remodeling, but rheumatologists say a better understanding of the mechanisms of bone resorption, formation is needed to make an impact

    Build Up Bone

    June 1, 2007

    Current management of osteoporosis

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences